Perugia, Italy

Francesca Fallarino

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Gh Care Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesca Fallarino. Retrieved from https://idiyas.com/inventor/francesca-fallarino-ze25l0y3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesca Fallarino: Innovator in Diabetes Treatment

Introduction

Francesca Fallarino is a notable inventor based in Perugia, Italy. She has made significant contributions to the field of medical science, particularly in the treatment of Type 1 diabetes mellitus. Her innovative approach involves the use of Sertoli cells microencapsulated into hydrogel-based microcapsules.

Latest Patents

Francesca holds a patent for a microencapsulation process of Sertoli cells, which is crucial for the prevention and treatment of Type 1 diabetes mellitus. The invention focuses on producing microcapsules, preferably shaped as microspheres, that can effectively deliver therapeutic agents.

Career Highlights

Throughout her career, Francesca has worked with companies such as Gh Care Inc. and Gh Care, Inc. D/b/a Altucell, Inc. Her work in these organizations has allowed her to further develop her innovative ideas and contribute to advancements in diabetes treatment.

Collaborations

Francesca has collaborated with notable individuals in her field, including Riccardo Calafiore and Giovanni Luca. These partnerships have enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Francesca Fallarino's work exemplifies the intersection of innovation and medical science. Her contributions to the treatment of Type 1 diabetes through her patented microencapsulation process highlight her role as a leading inventor in this vital area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…